Table 3.
The association of baseline characteristics with nonalcoholic fatty liver disease in pre- or postmenopausal women
|
Premenopausal women (n = 1023) |
Postmenopausal women (n = 549) |
|||||
| Normal US | NAFLD | P Value | Normal US | NAFLD | P Value | |
| Number of subjects (%) | 962 | 61 (6) | 468 | 81 (15) | ||
| Mean age ± SD, yr | 42.2 (6.4) | 44.7 (6.1) | 0.003 | 56 (5.5) | 55.9 (5.4) | 0.874 |
| Number (%) who met a criterion of metabolic syndrome | ||||||
| Body mass index | 75 (8) | 32 (52) | < 0.001 | 37 (8) | 43 (53) | < 0.001 |
| Glucose | 24 (2) | 15 (25) | < 0.001 | 25 (5) | 8 (10) | < 0.001 |
| Blood pressure | 94 (10) | 21 (34) | < 0.001 | 104 (22) | 35 (43) | < 0.001 |
| HDL-cholesterol | 221 (23) | 31 (51) | < 0.001 | 128 (27) | 48 (59) | < 0.001 |
| Triglycerides | 29 (3) | 13 (21) | < 0.001 | 36 (8) | 21 (26) | < 0.001 |
| Number (%) who met ≥3 criteria of metabolic syndrome | 18 (2) | 17 (28) | < 0.001 | 26 (6) | 23 (28) | < 0.001 |
| Number (%) light-drinkers | 472 (49.1) | 24 (3.9) | 0.15 | 190 (40.6) | 34 (42.0) | 0.81 |
| Number (%) current smokers | 48 (5.0) | 4 (6.6) | 0.54 | 34 (7.3) | 5 (6.2) | 0.64 |
| Number (%) ex-smokers | 103 (1.1) | 5 (8.2) | 0.67 | 50 (10.7) | 5 (6.2) | 0.31 |
| Number (%) regular exercisers | 181 (18.8) | 8 (13.1) | 0.31 | 105 (22.4) | 15 (18.5) | 0.47 |
This table summarizes the baseline data of 1572 women, excluding 257 subjects with hormone replacement therapy. We separated the subjects into pre- or postmenopausal groups. US: Abdominal ultrasonography; NAFLD: Nonalcoholic fatty liver disease; HDL: High-density lipoprotein.